Reformulated Valproic Acid through CSF Infusion Pump

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/30/2019

Pipeline Type

New Formulations and Indications

Phase Of Development

Phase 2

Sponsors and Collaborators

Cerebral Therapeutics, EF

Mechanism of Action

Mechanism Description

Implantable, programmable drug delivery pump for ICV delivery of Valproate

Populations Tested In

Drug resistant seizures

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation- Investment

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.